Clinical Trials on Mukolipidóza typu 4

Total 56472 results

LG Life Sciences

Completed

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Completed

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) (STABLE)

Type 2 Diabetes Mellitus

Korea, Republic of
AstraZeneca
Eli Lilly and Company

Completed

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

Type 2 Diabetes Mellitus

United States
Lexicon Pharmaceuticals

Completed

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States
Gilead Sciences

Completed

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Type 2 Diabetes Mellitus

United States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Tel Aviv University

Completed

Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes (WheyGLP-1)

Type 2 Diabetes Mellitus

Israel
Mitsubishi Tanabe Pharma Corporation

Completed

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

Type 2 Diabetes Mellitus

Korea, Republic of
Nagaoka Red Cross Hospital
Kurume University

Unknown

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Type 2 Diabetes Mellitus

Japan
HealthInsight
Center for Technology and Aging; Voxiva

Unknown

Mobile Health Technology as an Intervention for Diabetes Self-Management (Care4Life)

Type II Diabetes Mellitus

United States
Tirang R. Neyestani
Tehran University of Medical Sciences

Completed

Vitamin D Receptor Polymorphisms and Efficacy of Vitamin D-Fortified Yogurt Drink in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Iran, Islamic Republic of
Cytos Biotechnology AG

Completed

Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany, Switzerland
Takeda

Completed

Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
National Taiwan University Hospital
National Science Council, Taiwan

Completed

YKL-40 and Complications in Type 2 Diabetes

Type 2 Diabetes Mellitus

Taiwan
Eli Lilly and Company

Completed

A Study for Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Brazil, Canada, Mexico, India, Australia, China, Korea, Republic of
GlaxoSmithKline

Completed

Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

Type 2 Diabetes Mellitus
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (SERENADE)

Type 2 Diabetes Mellitus

United States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
Landsteiner Institut
Medical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaborators

Completed

Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans (RECO1)

Type 2 Diabetes Mellitus

Austria
University of Campania "Luigi Vanvitelli"

Completed

Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat Diet

Type 2 Diabetes Mellitus

Italy
National Institute of Nursing Research (NINR)

Completed

Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring

Type 2 Diabetes Mellitus

United States
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Type 2 Diabetes Mellitus

Japan
University Hospital, Caen

Completed

Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes (Smartguard)

Type 1 Diabetes Mellitus Maturity Onset

France
Asahi Kasei Pharma Corporation

Recruiting

Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
University of Liverpool
AstraZeneca; Clinical Practice Research Datalink

Active, not recruiting

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE)

Type 2 Diabetes Mellitus

United Kingdom
Regor Pharmaceuticals Inc.

Terminated

A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Charles Drew University of Medicine and Science
National Center for Research Resources (NCRR)

Terminated

Insulin Glargine Versus Twice-Daily NPH

Type 2 Diabetes Mellitus

United States
Endocrine Research Society

Completed

Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
AstraZeneca

Completed

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings (DISCOVER)

Type 2 Diabetes Mellitus

Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
Takeda

Completed

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

Type 2 Diabetes Mellitus

Korea, Republic of
Sanofi

Completed

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy (EDITION II)

Type 2 Diabetes Mellitus

United States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
Eli Lilly and Company

Completed

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Sanofi
Hanmi Pharmaceutical Company Limited

Terminated

Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O)

Type 2 Diabetes Mellitus

Estonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
Theracos

Completed

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Canada
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States, Japan, Czechia, Hungary, Poland, Spain
University of Michigan
Twine Clinical Consulting

Completed

Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States
Nanjing University of Traditional Chinese Medicine

Completed

Effects of Aerobic Training on Pancreatic Fat and Cognitive Function in T2DM Patients

Type 2 Diabetes Mellitus

China
Kaohsiung Medical University Chung-Ho Memorial...

Completed

The Effectiveness of Intervention on Insulin Injection

Type 2 Diabetes Mellitus

Taiwan
Academy of Nutrition and Dietetics

Completed

Evidence-Based Nutrition Practice Guidelines of Toolkit and Preliminary Outcomes

Type 2 Diabetes Mellitus
Yaounde Central Hospital

Completed

Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients (CARE-PLP)

Type 2 Diabetes Mellitus

Cameroon
Daiichi Sankyo Co., Ltd.

Completed

Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Merck Sharp & Dohme LLC
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

Type 2 Diabetes Mellitus
University of British Columbia

Completed

Impact of Bedtime Snacks on Glucose Control in Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
BioKier Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of BKR-013 on Average Daily Glucose Levels

Type 2 Diabetes Mellitus

United States
NuSirt Biopharma

Completed

Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States
BHV Pharma
Integrium

Completed

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes (BRID)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
NuSirt Biopharma

Completed

An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States
Tri-Service General Hospital

Completed

Exercise-induced Blood Glucose Response in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
AstraZeneca

Completed

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Type 2 Diabetes Mellitus

China

Clinical Trials on Mukolipidóza typu 4

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations